Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Turnstone Biologics
Biotech
Turnstone ends final TIL program over costs, plots more layoffs
Four months after laying off 60% of its workforce, Turnstone is planning further redundancies after giving up on its final clinical-stage candidate.
James Waldron
Feb 4, 2025 10:30am
Turnstone lays off 60%, shakes up C-suite to stretch out cash
Oct 11, 2024 8:05am
Turnstone narrows cell therapy focus to 'high unmet need' tumors
Aug 15, 2024 7:46am
Turnstone turns fortunes around with $80M IPO haul
Jul 21, 2023 9:25am
Booted by Big Pharma, Turnstone files IPO to fund cell therapies
Jun 13, 2023 9:40am
Takeda cuts ties to cancer drug landed in $120M Turnstone deal
Jul 28, 2022 7:00am